Vital Images develops new 3-D software

Article

Vital Images has filed a 510(k) application with the Food andDrug Administration for a new, more advanced version of its 3-Dimage processing software, according to the company's parent,Bio-Vascular of St. Paul, MN. The new version builds on VitalImages'

Vital Images has filed a 510(k) application with the Food and

Drug Administration for a new, more advanced version of its 3-D

image processing software, according to the company's parent,

Bio-Vascular of St. Paul, MN. The new version builds on Vital

Images' existing 3-D product, VoxelView 2.5, but is faster and

easier to use. The company plans to display the new version at

this year's Radiological Society of North America meeting. Vital

Images has an agreement with ATL of Bothell, WA, to develop 3-D

ultrasound image processing software (SCAN 8/28/96).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.